Consolidated Financial Results of the Company for the quarter ended June 30, 2026. For Anthem Biosciences…
As filed · Press Release
EarningsMajormateriality 75 out of 100
What happened
FactConsolidated Financial Results of the Company for the quarter ended June 30, 2026. For Anthem Biosciences Limited. (Formerly known as Anthem Biosciences Private Limited).
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedEarlierQ1 FY27
Our employee cost has been amongst the lowest vis-a-vis as a percentage of sales vis-a-vis the industry, although it might look for this quarter about 18.8%, it might look higher, but that's largely on account of the muted revenue for Q1 FY27.
NowQ1 FY27
But if you look at on an FY27 full year basis, we will be largely around 13% sort of number as a percentage of sales.
Change
FactTimeline delay
Implication
CapitSignal interpretationThe stated timeline moved by 3 quarter(s) (earlier to FY27).confidence 60%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Other expenses will also be in a similar 9% sort of the percentage of sales. (management committed by FY27)
- But if you look at on an FY27 full year basis, we will be largely around 13% sort of number as a percentage of (management committed by FY27)
Evidence
- Press Release(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%